Cosmos Pharmaceutical Corp
TSE:3349
Cosmos Pharmaceutical Corp
Revenue
Cosmos Pharmaceutical Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cosmos Pharmaceutical Corp
TSE:3349
|
Revenue
¥900.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Sundrug Co Ltd
TSE:9989
|
Revenue
¥736.9B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
Tsuruha Holdings Inc
TSE:3391
|
Revenue
¥1T
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Revenue
¥1.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Revenue
¥744.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
MatsukiyoCocokara & Co
TSE:3088
|
Revenue
¥1T
|
CAGR 3-Years
22%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
See Also
What is Cosmos Pharmaceutical Corp's Revenue?
Revenue
900.1B
JPY
Based on the financial report for Nov 30, 2023, Cosmos Pharmaceutical Corp's Revenue amounts to 900.1B JPY.
What is Cosmos Pharmaceutical Corp's Revenue growth rate?
Revenue CAGR 10Y
10%
Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Cosmos Pharmaceutical Corp have been 8% over the past three years , 9% over the past five years , and 10% over the past ten years .